Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK – 18 ...

The Cell & Gene Therapy Manufacturing Services market is driven by increasing investments in advanced therapies, rising ...

The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...

Bothnia dystrophy, a hereditary form of blindness, significantly affects people in the Västerbotten region of Sweden, ...

Bothnia dystrophy is a form of hereditary blindness, prevalent in the region Västerbotten in Sweden. A new study at ...

A new study describes the use of artificial intelligence (AI) in designing a new generation of capsids, the structures that ...

D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for ...

Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...

In an early phase trial, gene therapy showed an ability to restore function to rods and cones as well as functional vision ...

Co-expressing NPY and its inhibitory receptor Y2 in excitatory hippocampal cells allows inhibitory autoregulation of ...

Scientists from Spirovant Sciences describe SP-101, a novel adeno-associated virus (AAV) gene therapy for the treatment of ...

Researchers at the Karolinska Institute continue to investigate whether gene therapy can improve vision in people with ...